Co-Authors
This is a "connection" page, showing publications co-authored by MADELEINE DUVIC and PRIYADHARSINI NAGARAJAN.
Connection Strength
0.763
-
Primary cutaneous anaplastic large-cell lymphoma: Complete remission for 13?years after denileukin diftitox. JAAD Case Rep. 2017 Nov; 3(6):501-504.
Score: 0.160
-
An adolescent with granulomatous mycosis fungoides infiltrating skeletal muscle successfully treated with oral prednisone. JAAD Case Rep. 2017 Jul; 3(4):276-279.
Score: 0.156
-
Verrucous presentation in patients with mycosis fungoides. Int J Dermatol. 2016 Mar; 55(3):e126-9.
Score: 0.139
-
Differential Upregulation of Th1/Th17-Associated Proteins and PD-L1 in Granulomatous Mycosis Fungoides. Cells. 2024 Feb 27; 13(5).
Score: 0.062
-
Is immunohistochemical expression of GATA3 helpful in the differential diagnosis of transformed mycosis fungoides and primary cutaneous CD30-positive T cell lymphoproliferative disorders? Virchows Arch. 2021 Aug; 479(2):377-383.
Score: 0.050
-
Lichenoid dermatitis from immune checkpoint inhibitor therapy: An immune-related adverse event with mycosis-fungoides-like morphologic and molecular features. J Cutan Pathol. 2019 Nov; 46(11):872-877.
Score: 0.045
-
Differential expression of CCR4 in primary cutaneous gamma/delta (?/d) T cell lymphomas and mycosis fungoides: Significance for diagnosis and therapy. J Dermatol Sci. 2018 Jan; 89(1):88-91.
Score: 0.039
-
Primary Cutaneous T-Cell Lymphomas Showing Gamma-Delta (?d) Phenotype and Predominantly Epidermotropic Pattern are Clinicopathologically Distinct From Classic Primary Cutaneous ?d T-Cell Lymphomas. Am J Surg Pathol. 2017 Feb; 41(2):204-215.
Score: 0.038
-
Diverse types of dermatologic toxicities from immune checkpoint blockade therapy. J Cutan Pathol. 2017 Feb; 44(2):158-176.
Score: 0.038
-
Loss of CD30 expression after treatment with brentuximab vedotin in a patient with anaplastic large cell lymphoma: a novel finding. J Cutan Pathol. 2016 Dec; 43(12):1161-1166.
Score: 0.037